NA
HALO icon

NewEdge Advisors’s Halozyme HALO Stock Holding History

NewEdge Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Sell
3,961
-972
-20% -$66.3K ﹤0.01% 2463
2026
Q1 		$319K Sell
4,933
-6,643
-57% -$468K ﹤0.01% 2300
2025
Q4 		$779K Buy
11,576
+4,643
+67% +$312K ﹤0.01% 1643
2025
Q3 		$508K Buy
6,933
+6,811
+5,583% +$452K ﹤0.01% 1793
2025
Q2 		$6.35K Hold
122
– – ﹤0.01% 3346
2025
Q1 		$7.79K Sell
122
-5
-4% -$290 ﹤0.01% 3181
2024
Q4 		$6.07K Hold
127
– – ﹤0.01% 3178
2024
Q3 		$7.27K Hold
127
– – ﹤0.01% 3037
2024
Q2 		$6.65K Sell
127
-228
-64% -$10K ﹤0.01% 2998
2024
Q1 		$14.4K Sell
355
-107
-23% -$4.01K ﹤0.01% 2740
2023
Q4 		$17.1K Buy
462
+249
+117% +$9.38K ﹤0.01% 2634
2023
Q3 		$8.14K Buy
213
+52
+32% +$2.13K ﹤0.01% 2650
2023
Q2 		$5.81K Sell
161
-1,161
-88% -$39.6K ﹤0.01% 2760
2023
Q1 		$50.5K Sell
1,322
-272
-17% -$12.8K ﹤0.01% 1991
2022
Q4 		$9.7K Buy
+1,594
New +$81.6K ﹤0.01% 2381

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

NewEdge Advisors's HALO Position: Q2 2026 in Review

NewEdge Advisors reduced its Halozyme (HALO) stake by 20% in Q2 2026, selling an estimated $66.3K and leaving 3,961 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #2463.

NewEdge Advisors first reported a position in HALO in Q4 2022 and has held it in 15 quarters since. The position peaked at $779K in Q4 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • NewEdge Advisors held 3,961 shares of Halozyme worth $310K as of Q2 2026.
  • NewEdge Advisors sold 972 Halozyme shares in Q2 2026, an estimated $66.3K.
  • Halozyme made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2463 holding.
  • NewEdge Advisors first reported a position in Halozyme in Q4 2022 and has held it in 15 quarters since.
  • NewEdge Advisors's Halozyme position peaked at $779K in Q4 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.